BDNF and Alzheimer disease: Therefore, another test of the hypothesis that the BDNF Val66Met polymorphism increase risk of AD would be if individuals with MCI and high Aβ who are BDNFMet carriers show greater decline in episodic memory and hippocampal volume than BDNFVal homozygotes.